Cabito, Caroline .

HRN: 28-64-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
CLINDAMYCIN 300MG (CAP)
03/03/2026
03/10/2026
IV
600mg
Q6h
Infected Breast Mass, Left
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: